Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

MEDIFAST INC MED

Growth Flags show if company had growth for consecutive years ,
Insider Buys alert about insiders buying in the last 12 month

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.
Mar '16
Jun '16
Sep '16
Dec '16
Mar '17
Jun '17
Sep '17
Dec '17
Mar '18
Jun '18
Sep '18
Dec '18
Mar '19
Jun '19
Sep '19
Dec '19
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
P/E ratio
18.19
23.10
25.36
27.82
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
P/S ratio
1.32
1.45
1.64
1.81
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
P/FCF ratio
14.08
13.67
17.77
0.00
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
P/Operating CF
46.71
35.54
64.51
(1,579.31)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
P/B ratio
3.99
4.31
4.72
5.18
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Price to Tangible BV
3.99
4.31
4.72
5.18
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/Sales
1.06
1.16
1.34
1.53
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/EBITDA
8.11
10.00
11.44
12.87
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/Operating CF
10.63
10.35
13.17
16.60
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/FCF
11.27
10.91
14.52
(110.33)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Quick Ratio
2.98
3.34
3.20
3.20
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Current Ratio
3.72
4.02
3.97
4.15
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Debt/EBITDA
(9.10)
(12.29)
(7.93)
(9.61)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Debt/Assets
0.00%
0.00%
0.00%
0.00%
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Debt/Equity
0.00
0.00
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Asset Turnover
2.27
2.30
2.30
2.31
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating CF/Net income
1.80
3.25
1.14
(0.08)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capex/Depreciation
0.23
(0.33)
(0.91)
(19.84)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Interest Coverage
0.00
0.00
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Research and Development Expense of Revenue
0.00%
0.00%
0.00%
0.00%
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Selling, General and Administrative Expense of Revenue
64.86%
67.75%
63.01%
64.78%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Intangible Assets out of Total Assets
0.00
0.00
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Share Based Compensation of Revenue
0.72%
0.94%
0.99%
2.49%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Graham Net Nets
0.17
0.18
0.17
0.15
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Graham Number
16.82
15.82
16.39
16.60
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
Earnings Yield
5.50%
4.33%
3.94%
3.59%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow Yield
7.10%
7.32%
5.63%
(0.77%)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Revenue per Share
6.10
6.02
5.79
5.28
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating CF per Share
0.65
0.94
0.59
(0.03)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capex per Share
0.03
(0.04)
(0.11)
(2.32)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow per Share
0.68
0.90
0.48
(2.34)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Cash per Share
6.04
6.74
6.93
6.49
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shareholders Equity per Share
7.58
7.73
8.01
8.11
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Interest Debt per Share
0.00
0.00
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Book value per Share
7.58
7.73
8.01
8.11
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow
8.04
10.59
5.68
(27.73)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Working Capital
67.36
73.44
77.16
76.88
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capital Expenditures
0.37
(0.47)
(1.26)
(27.41)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Current Asset Value
62.63
70.95
74.64
76.10
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Receivables
2.21
1.81
1.50
1.51
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Payables
24.64
21.81
22.30
23.40
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Inventory
13.71
11.89
13.39
15.82
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Assets
119.82
117.73
118.94
118.67
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Common Equity
87.35
89.73
90.87
92.30
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/EBIT
10.08
12.65
14.20
15.67
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capex to Sales
(0.01)
0.01
0.02
0.44
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Profit Margin
5.89%
4.77%
8.84%
6.58%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Price to Operating Income
12.59
15.84
17.37
18.52
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us